Can a simple blood test predict the best eye treatment for diabetes patients?

NCT ID NCT06984822

Recruiting now Knowledge-focused Sponsor: Vastra Gotaland Region Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is for people with diabetic macular edema, a condition that causes vision loss. Researchers want to see if certain substances in the blood and patterns on eye scans can predict how well a patient will respond to two common treatments: anti-VEGF injections or a dexamethasone implant. The goal is to find markers that help doctors choose the right treatment for each person. The study will enroll 150 adults and does not test a new drug.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Anti-VEGF treatment or Dexamethasone implant
What this could lead to: If successful, this could help doctors choose the best treatment for each patient with diabetic macular edema, improving vision outcomes.
What could go wrong: This is an observational study, not a treatment trial. It will not directly test if one drug is better, and results may not change practice immediately.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus diabetic macular edema hyperglycemia vision disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS DIABETIC MACULAR EDEMA HYPERGLYCAEMIA (DIABETIC) OXIDATIVE STRESS VASCULAR ENDOTHELIAL GROWTH FACTOR VEGF VISUAL IMPAIRMENT

Contacts and locations

Locations

Sahlgrenska University Hospital, Department of Ophthalmology
RECRUITING

Mölndal, 431 80, Sweden
Ögonmottagning Mölndal/SU
NOT_YET_RECRUITING

Mölndal, 43130, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.